Top Banner
Chia-Hsun Lin, MD Chia-Hsun Lin, MD Chief, Cardiovascular Chief, Cardiovascular Surgery Surgery Shin Kong Memorial Shin Kong Memorial Hospital Hospital Assistant Professor Assistant Professor Fu Jen Catholic Fu Jen Catholic University University Taipei, Taiwan Taipei, Taiwan Hybrid TEVAR for the Hybrid TEVAR for the Treatment of Aortic Treatment of Aortic Dissection Dissection
52
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Hybrid tevar for the treatment of aortic dissection

Chia-Hsun Lin, MDChia-Hsun Lin, MDChief, Cardiovascular Chief, Cardiovascular

SurgerySurgeryShin Kong Memorial HospitalShin Kong Memorial Hospital

Assistant Professor Assistant Professor Fu Jen Catholic UniversityFu Jen Catholic University

Taipei, TaiwanTaipei, Taiwan

Hybrid TEVAR for the Hybrid TEVAR for the Treatment of Aortic Treatment of Aortic

DissectionDissection

Page 2: Hybrid tevar for the treatment of aortic dissection

• Acute type A dissectionAcute type A dissection

- indicated for total arch - indicated for total arch repairrepair• Chronic type B dissectionChronic type B dissection

- indicated for TEVAR with - indicated for TEVAR with no no

suitable proximal landing suitable proximal landing sitesite

at zone 2at zone 2

Hybrid TEVAR for the Hybrid TEVAR for the Treatment of Aortic Treatment of Aortic

DissectionDissection

Page 3: Hybrid tevar for the treatment of aortic dissection

• Acute type A dissection -Acute type A dissection -

indicated for total arch repair,indicated for total arch repair, due to arch aneurysm formation (>4cm), tears in arch or proximal DTA, or supra-aortic arteries dissection• Chronic type B dissectionChronic type B dissection

Hybrid TEVAR for the Hybrid TEVAR for the Treatment of Aortic Treatment of Aortic

DissectionDissection

Page 4: Hybrid tevar for the treatment of aortic dissection

• Most challenging, perioperative mortality is still significant despite improvement in surgical techniques

• Emergent ascending aorta or hemiarch replacement to achieve primary goal of immediate survival

Type A Aortic DissectionType A Aortic Dissection

Page 5: Hybrid tevar for the treatment of aortic dissection

• Residual distal false lumen patency 50-70%of patients after ascending aorta replacement

• Residual distal false lumen patency 15-30%of patients after total arch replacement

- Ann Thorac Surg 2007;84:1955-64

- J Thorac Cardiovasc Surg 2006;131: 862-7

Type A Aortic DissectionType A Aortic Dissection

Page 6: Hybrid tevar for the treatment of aortic dissection

Type A S/P Ascending Aorta Replacement with

Residual Type B DissectionMore Extensive

Aortic Repair is needed !!

Page 7: Hybrid tevar for the treatment of aortic dissection

Hybrid TEVAR for Type Hybrid TEVAR for Type A Aortic DissectionA Aortic Dissection

One-stop treatment of the entire thoracic aorta•Open repair for proximal aorta and aortic arch•TEVAR for DTA tear coverage and apposition of intimal dissecting membrane to the adventitia

Page 8: Hybrid tevar for the treatment of aortic dissection

“High-risk” Arch Repair

Profound hypothermia• Prolonged CPB time - end organs

dysfunction• Prolonged myocardial ischemic time - deteriorated myocardial function • Induced coagulopathy – excessive bleeding

Circulatory arrest• Antegrade cerebral perfusion - clustered tubes in surgical field - emboli from carotid cannulation

Page 9: Hybrid tevar for the treatment of aortic dissection
Page 10: Hybrid tevar for the treatment of aortic dissection

Our Operative Techniques

NO Deep Hypothermic Circulatory Arrest •32℃ CPB•Bi-arterial perfusion, right axillary and femoral artery•Ascending aortic cross-clamping•HTK arrest

Page 11: Hybrid tevar for the treatment of aortic dissection

Proximal aorta (root) reconstruction

/ 4-branched graft

Innominate artery anastomosis and right

axillary to coronary perfusion / rewarming

Figure 1

Figure 2

Page 12: Hybrid tevar for the treatment of aortic dissection

LCCA anastomosis/ heartbeat resumed

Distal graft anastomosis under clamping of aorta (or

open anastomosis under lower body CA)

Figure 3

Figure 4

Page 13: Hybrid tevar for the treatment of aortic dissection

Off CPB and antegrade stentgraft

deployment

LSCA anastomosis

Figure 5

Figure 6

Page 14: Hybrid tevar for the treatment of aortic dissection

Stentgraft in Hybrid Arch Deployed after Circulation

Restoration• Frozen elephant trunk,

extending the proximal graft into DTA

• Endovascular repair, covering the DTA entries accurately

• Hemostasis of anastomosis, landing in proximal graft

Page 15: Hybrid tevar for the treatment of aortic dissection

4.5cm Arch dissection

Carotid a. dissection

Acute Type A Dissection

Page 16: Hybrid tevar for the treatment of aortic dissection
Page 17: Hybrid tevar for the treatment of aortic dissection
Page 18: Hybrid tevar for the treatment of aortic dissection

Ascending Aorta Replacement, Arch

Debranching and TEVAR

Page 19: Hybrid tevar for the treatment of aortic dissection
Page 20: Hybrid tevar for the treatment of aortic dissection

Post-op 2M

Post-op 2M

Post-op 1M

Aorta Remodeling within Stent

Post-op 6M

Post-op 9M

Page 21: Hybrid tevar for the treatment of aortic dissection

Post-op 6M

Post-op 1M

Aorta Remodeling at Stent End

Post-op 15M

Post-op 9M

Page 22: Hybrid tevar for the treatment of aortic dissection

Post-op 6M 13.5cm

Post-op 15M 10.2cm

False Lumen Regression (Above Celiac Artery)

Post-op 9M 11.4cm

Post-op 1M 14.4cm

Page 23: Hybrid tevar for the treatment of aortic dissection

• Acute type A dissectionAcute type A dissection

• Chronic type B dissection Chronic type B dissection --

indicated for TEVAR with no indicated for TEVAR with no suitable proximal landing suitable proximal landing site at zone 2site at zone 2

Hybrid TEVAR for the Hybrid TEVAR for the Treatment of Aortic Treatment of Aortic

DissectionDissection

Page 24: Hybrid tevar for the treatment of aortic dissection

Chronic Type B Chronic Type B DissectionDissection

• Mortality with nearly one in four patients (24.9%) within 3 years

• The poor long-term prognosis is determined by patient-specific risk factors and dissection-related late sequelae in 20-50% of patients, including new dissection associated with new complications, rupture of a weak false channel and saccular or fusiform aneurysmal degeneration

- Ann Thorac Surg 2002;74;S1840-3, 1857-63

- N Engl J Med 2007;357:349-59

Page 25: Hybrid tevar for the treatment of aortic dissection

Contemporary Results of Open Repair of DTA

On the basis of 1898 reported cases in the hands of experienced surgeons•Mortality rate 4.8%•Stroke rate 2.7%•Lower extremity paralysis rate 3.4%•Overall 5 and 10-year survival estimates are 60% and 38%

Page 26: Hybrid tevar for the treatment of aortic dissection

Contemporary Results of Contemporary Results of Open Repair of DTAOpen Repair of DTA

• US Medicare data analysis Mortality risk 20% at 30 days and 31%

at 12 months (J Vasc Surg 2006;43:217-222)

• UK National adult cardiac surgical database in 2000

31.5% mortality rates for descending aorta replacement

Page 27: Hybrid tevar for the treatment of aortic dissection

Contemporary Results of Contemporary Results of TEVARTEVAR

A Meta-analysis in Aortic Dissection

(Eur Heart J 2006;27:489-98)

• 39 published studies, 609 patients• 96% type B dissection (58% acute, 42% chronic)• Procedure success 98.2+0.5%• 30-day mortality 5.3%• Stroke 1.9% and paraplegia 0.8%• False lumen thrombosis 75.5%• Total re-intervention rate 11.9%• Aortic rupture during follow-up 2.3%

Page 28: Hybrid tevar for the treatment of aortic dissection

Endoleak in TEVAR for Endoleak in TEVAR for Type B Aortic DissectionType B Aortic Dissection

• The prognosis of type I endoleak is poor and all efforts to avoid it should be made

• The shorter the distance between the opening of the LSCA and the entry tear, the greater the chance of an endoleak

- J Thorac Cardiovasc Surg 2010;139:1548-53

Page 29: Hybrid tevar for the treatment of aortic dissection

Hybrid TEVAR for Type Hybrid TEVAR for Type B Aortic DissectionB Aortic Dissection

• Sternotomy to create secure proximal landing zone, including in situ supra-aortic arteries bypass and aortic banding

• TEVAR for DTA tear coverage to induce the false lumen thrombosis and to promote the aortic remodeling

Page 30: Hybrid tevar for the treatment of aortic dissection

Hybrid TEVAR - Aorta to IA, LCCA, LSCA Bypass and Aortic Banding

Page 31: Hybrid tevar for the treatment of aortic dissection

Post-op 3 months, False Lumen Aneurysm Thrombosis

Page 32: Hybrid tevar for the treatment of aortic dissection

Post-op 6 months, ProgressiveFalse Lumen Aneurysm

Regression

Page 33: Hybrid tevar for the treatment of aortic dissection

Post-op 6 months, ProgressiveFalse Lumen Aneurysm

Regression

Page 34: Hybrid tevar for the treatment of aortic dissection

Post-op 12 months, Progressive

False Lumen Aneurysm Regression

Page 35: Hybrid tevar for the treatment of aortic dissection

37 year-old male- Chronic type B for 3 years- Dissecting TAA- Type III archSurgical Alternatives• Open repair • C-C bypass and zone 1 TEVAR

• Hybrid TEVAR arch surgery

Page 36: Hybrid tevar for the treatment of aortic dissection

Ascending and proximal arch replacement,

arch debranching and TEVAR

Antegrade TEVAR

Page 37: Hybrid tevar for the treatment of aortic dissection

Post-op 12 Month, ProgressiveFalse Lumen Aneurysm

Thrombosis and Regression- Proximal Entry Site

Page 38: Hybrid tevar for the treatment of aortic dissection

Post-op 12 Month, ProgressiveTrue Lumen re-expansion and

Aortic Remodeling- Proximal DTA

Page 39: Hybrid tevar for the treatment of aortic dissection

Post-op 12 Month, ProgressiveTrue Lumen Re-expansion and

Aortic Remodeling- Distal DTA (Stent End)

Page 40: Hybrid tevar for the treatment of aortic dissection

Post-op 12 Month, ProgressiveFalse Lumen Aneurysm

Thrombosis and Regression- Distal DTA

Page 41: Hybrid tevar for the treatment of aortic dissection

Post-op 12 months, Progressive

False Lumen Aneurysm Thrombosis and Regression- Distal Re-entry at Celiac

Page 42: Hybrid tevar for the treatment of aortic dissection

Post-op 18 months, Positive Aortic Remodeling

Page 43: Hybrid tevar for the treatment of aortic dissection

PatientsPatients• 2010 – 2012, 64 patients with aortic

dissection underwent TEVAR procedures

• M 77%, HTN 82%, mean age 55.7 (31-73)

• 22 patients with acute type A • 42 patients with chronic type B - 32 isolated TEVAR - 10 Hybrid TEVAR (zone 0 and 1)

Page 44: Hybrid tevar for the treatment of aortic dissection

ResultsResults22 Type A s/p hybrid TEVAR•Two hospital death 9% (2/22) - One with pre-op stroke and cons. disturbance - One with pre-op AMI, shock and ischemic bowel

•No mortality in pre-op stable patients•No permanent neurologic deficit•100% (20/20) false lumen thrombosis and regression at stentgraft level•95% (19/20) false lumen thrombosis and regression at diaphragm level•No dilatation of visceral aorta with residual dissection

Page 45: Hybrid tevar for the treatment of aortic dissection

F

Post-op 1M

Page 46: Hybrid tevar for the treatment of aortic dissection

F

Intima Break at Distal Stent Aorta Remodeling Limited in

Stent

Post-op 1M

Page 47: Hybrid tevar for the treatment of aortic dissection

ResultsResults

10/42 Type B s/p Hybrid TEVAR - 5 AsAo to LCCA-LSCA - 3 AsAo to In-LCCA-LSCA and aortic banding - 2 Hybrid arch

•No hospital mortality•No permanent neurologic deficit •100% (10/10) false lumen thrombosis and regression at stentgraft level•80% (8/10) false lumen thrombosis and regression at diaphragm level

Page 48: Hybrid tevar for the treatment of aortic dissection

Hybrid TEVAR Type An=22

Type Bn=10

Reopen 27.3% 0

Prolong MV >48hours

22.7% 10%

Renal Deterioration

9.1% 10%

CVA/ TIA 4.5% 0

SCI 0 0

Mortality 9.1% 0

ResultsResults

Page 49: Hybrid tevar for the treatment of aortic dissection

Hybrid TEVAR Hybrid Aneurysm

n=33

Hybrid Dissection

n=7

MI 6% 0

Respiratory failure

33% 20%

Renal failure 15% 20%

CVA/ TIA 18% 40%

SCI 15% 0

Mortality 24% 0

Hybrid TEVAR: Pushing the Hybrid TEVAR: Pushing the EnvelopEnvelop

(J Vasc Surg 2010;51:259-66)(J Vasc Surg 2010;51:259-66)

Page 50: Hybrid tevar for the treatment of aortic dissection

ConclusionConclusion• Hybrid Arch surgery with

modified four-branched graft technique and TEVAR provided favorable early and mid-term outcomes in type A dissection

• Single-stage operation combined with antegrade TEVAR is feasible and effective to extend the repair down to the descending aorta

Page 51: Hybrid tevar for the treatment of aortic dissection

ConclusionConclusion

• Hybrid procedures successfully extend the TEVAR applications in type B dissection patients with no suitable proximal landing zone

• For younger patients population in type B aortic dissection, hybrid TEVAR is safe and demonstrates satisfactory early and mid-term results

Page 52: Hybrid tevar for the treatment of aortic dissection

Thanks for Thanks for Your Your

AttentionAttention